We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Motoring now....Up it goes....and no wonder....This is worth 20p plus......We are profitable and the previous risk of dilution has gone,with the increasing orders now making this a compelling investment.....rerate only just started....
Well, good news for current holders is its stops so much dilution if KMK decide to give shares rather than interest.
I gave up reading IC a long time ago, it cost me an arm and a leg following it and perhaps especially ST. I have learnt to take various tipsters with a huge bag of salt, they seem wrong more often than not and especially in a flat or falling general market.
There is plenty of evidence to the contrary and not much supporting what you say.
Pedro. Your morse code blogs are missing a few dashes. Wonder if ST can advise.
20p seems realistic....Sales set to start rising,and profit now being made....All the risk profile of this share is history and the s,p should start to represent the true value....20p in a year ,I think....
I am not sure that the chart tells us very much. It could mean the price has bottomed and there will be a swift rise in price. The short term chart suggests that. It could mean that the price will spike in the short term and there will then be a further collapse and period of decline. The longer term chart suggests this. I hate to sound like a cracked record but a number of meaningful sales is the only thing that will drive this share up and reduce the current lack of trust of the company's management - unless the management changes and sentiment improves that way, of course.
Chart says it all
Sacked....His followers who make huge and consistent profits would be very upset.....He should be lauded as the greatest share pundit in the country....
Anyone who had such a track record of being consistently wrong should be sacked
Simon Thompson beats the market on a regular basis.has done for many years.followers make huge gains...This one he has seen the potential,but, got the timing wrong....Now is the time....Profitable and expanding orders will see this multibag.....
New boys beware.Those with Kromek, long term have had nothing but pain and devious promises . Bull from Thomson is just hot air. When the sp hits 20p and only then will i be convinced this is not just smoke and mirrors
Another update today on IC website from Simon Thompson. Could give it another boost
Escape velocity trajectory continuing so far, Scarfell. Can but hope.
@notsofastyou. This has been a nightmare ride for the vast. I believe that there has been a lot of insider trading happening on every spike. I believe that the sp has been manufactured at certain times. I still don’t have any faith in this but I’m down too much to bail on the very mere chance that it rerates. In other words, I may as well loose the lot. Good luck whichever way you choose to go.
Last Updated: 26/10/2023
Kromek - LGB Co
https://www.lgbco.com/quoted-landing-page/the-future-of-healthcare/kromek/
re states Philips CZT contract and est value and when likely revenue from deal will feed thro'
I sold mine at the worst possible time imaginable 3 days before Simon bloody thomsons article. Ah well that’s the way it goes sometimes I know some of you have had a tough ride so I hope you have better luck than me with this one and it continues to rise. I’m out I’m way too frustrated with this company to make non emotional decisions now.
Was pleased they said that the recent orders help underpin the current years revenue growth plans, all seems financially on track. The current game changer IHMO is the medical imaging progress that the market doesn’t seem to have recognised. Another contract in that space would be a massive boost and I suspect numerous deals are under discussion with KMK being the only independent supplier of CZT globally and the urgency to shift to CZT next generation detectors. The pathogen detection commercialisation has been slower than hoped but some very positive signs - if KMK also penetrated here I expect we would be a £billion company but the sooner they partner up in this sector the better I feel. Nice to see improved analysis and sentiment since I last looked at this board. IMHO DYOR
All companies have a risk.When a company hits profitable trading and starts to gain traction with orders then the risks attached to the share become much less....Risks are receding and because the market can see risks receding the s.p. is moving forward.....This is a lowly rated share with sentiment now changing....
Recent Bio detection news -
What's interesting to me is although it went very quite after the DARPA development contract ended it was almost immediately picked up by a UK security body MoD? with a follow on development and initial units supply and service contract.
This multi year contract is well underway and It appears that sufficient progress has been made to interest the US dept of homeland security to place a first contract with Kmk and although we weren't told much the term "Agnostic" was prominent, so along with the dozen or so know possible Bio weapon pathogens they want Unknown ones detectable as a primary function which is telling as it appears they believe Kromek can achieve this..all a world first, all of this tech.
I've just checked over the last few days and not seen any recent Bio detection development news from any other detection/security/defence companies anywhere, so Kromek are well placed I think and the news today of more financial help in development from a large un- named defence global is very interesting..maybe Kmk's future partner...have to wait and see...the prize is a national US Bio platform role out, and others to follow.
Even astra zeneca, microsoft, google have macro level and company specific risks. To say a company such as KMK, with its history, has addressed all risks is simply ridiculous.
Better to say the balance of risk / opportunity has changed - time to mitigate the former even further and execute on the latter.
We reached the critical point of profitable trading ,and now all the risks have been addressed the future is bright...Very bright....
Mike,
The RNSs last week and this morning very welcome, but considering the potential of the RNS last week thought the market response "muted".
Still believe the market is looking for the company to show it is run in an operationally efficient manner in the short / medium term in results from existing contracts - an extrapolating this efficiency in high margins, tight fixed cost and working capital management onto a future portfolio of growing and widening income streams.
Short term executional excellence will drive the share price.
We have been here several times before but perhaps this time we may reach escape velocity.
Kromek wins three new CBRN contracts, one with large new customer.
https://www.proactiveinvestors.co.uk/companies/news/1031469/kromek-wins-three-new-cbrn-contracts-one-with-large-new-customer-1031469.html